About this event
High-throughput, physiologically relevant in vitro models are required to improve the predictive value of toxicity testing. One such platform that may address the drawbacks of current toxicology models, is the OrganoPlate®, a high-throughput, perfusion-based microfluidic cell culture tool. This webinar will discuss in detail the development and application of well-established MIMETAS kidney-, liver-, and gut-on-a-chip model systems in toxicity testing. Additionally, we will review new toxicity models including brain- and placenta-on-a-chip.
Speaker: Dr Kristin Bircsak
Dr. Kristin Bircsak is a Principal Scientist with MIMETAS, in Gaithersburg, Maryland. In 2016, she received her Ph.D. in Toxicology from Rutgers University following which she completed a postdoctoral fellowship at the University of Pennsylvania. In her training, Kristin utilized various model system to characterize the negative impact of drugs and environmental chemicals on reproduction and development. In her role at MIMETAS, Kristin drives the development of innovative 3D in vitro organotypic models and assays. Her research is centered on recapitulating the liver and prostate tumor microenvironment to aid in the accurate prediction of safe and effective candidate compounds.
MIMETAS is a global leader in Organ-on-a-Chip disease models & technology. Its OrganoPlate® platform supports perfused 3D tissue modelling for permeability, migration and outgrowth studies as well as studying complex cell-cell interactions. The company offers its technology as off-the-shelve OrganoPlate® products, predesigned compound profiling & screening services (OrganoServices TM), and co-development of new compounds. The company is committed to the development of novel therapies and works with the majority of the pharmaceutical and biotech industry worldwide to make that happen. MIMETAS was founded in 2014 in Leiden, the Netherlands and has grown to a multinational company with operations in Asia, Europe and the United States.
MIMETAS offers OrganoPlates and develops human tissue and disease models for tomorrow’s medicines, chemicals and food.
Share this event